JoVE Logo
Faculty Resource Center

Sign In

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy

DOI :

10.3791/59949-v

December 17th, 2019

December 17th, 2019

14,066 Views

1Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania

We describe an approach to reliably generate chimeric antigen receptor (CAR) T cells and test their differentiation and function in vitro and in vivo.

Tags

Chimeric Antigen Receptor CAR T Cells

-- Views

Related Videos

article

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

article

A Spheroid Killing Assay by CAR T Cells

article

Preparation of Exosomes for siRNA Delivery to Cancer Cells

article

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

article

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

article

Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells

article

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

article

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

article

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

article

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved